Please read here the guidelines for lung cancer screening and detection. This can save your life!
Lung malignancy is the #1 cause of cancer death in the United States. In 2011, approximately 221,130 patients (115,060 men and 106,070 women) are estimated to be diagnosed with this malignancy. An estimated 156,940 people (85,600 men and 71,340 women) will die of this disease this year. Although cigarette use has decreased, we still have in America about 94 million current or former smokers who are at increased risk of developing lung tumors.
In the past, screening high risk but asymptomatic smokers has been ineffective with chest x-ray, with or without sputum cytology. However, a new study shows that screening with low dose chest CT reduces lung tumor death by 20%, in comparison to screening with chest x-ray alone (The National Lung Screening Trial Research Team. Reduced Lung Cancer Mortality with Low Dose Computed Tomographic Screening. New England Journal of Medicine, volume 365, pages 395-409, August 4, 2011). This clinical trial took place in 33 medical centers in the United States, and is funded by the National Cancer Institute.
To qualify for enrollment, the patients must have a 30 pack-year smoking history. About seven million people in the United States are in this category. For this clinical trial, 53,454 patients were enrolled between 2002 and 2004, and followed until 2009. The people were randomly assigned to chest CT or chest x-ray performed once yearly for three years. Lung tumor was discovered in 645 cases per 100,000 person-years in the CT group, in comparison to 572 in the chest x-ray group. There were 247 lung cancer deaths per 100,000 person-years in the CT group, versus 309 in the chest x-ray group. This calculates to a 20% reduction in mortality.
The bad news is that 96.4% of the abnormal chest CT findings turned out to be benign, meaning false positives. In other words, an abnormality on the CT translates into a cancer diagnosis in only 3.6% of the time. This means that many of these patients had more radiological tests done, tests that are in retrospect “unnecessary”. Some people underwent needle biopsies, bronchoscopy and/or chest surgeries in order to determine whether they have a lung tumor or not. Some of these cases resulted in complications (and even deaths), as expected of invasive procedures in the chest. The group that underwent screening with chest x-rays also experienced the same problem, as 94.5% of the abnormal chest x-ray findings also turned out to be benign.
Due to this high level of false positives, chest CT is currently not yet widely recommended for routine screening for lung cancer in the asymptomatic population at large. Certainly, if you are a current or past smoker and you have any chest symptoms (cough, pain, shortness of breath, hoarseness, wheezing, fatigue, weight loss, etc.), then you should go see a health care professional, who may determine that workup with chest x-ray and chest CT is warranted.
What every woman should know about ovarian cancer
Please read here to learn some basic facts about ovarian cancer, a most deadly disease in women. This can save your life!
Dr. Mai Brooks: Guidelines for Breast Cancer Screening and Detection
Breast cancer remains the most prevalent malignancy among women and the second leading cause of cancer-related deaths in American women. Early detection through screening mammograms is crucial for improving survival rates. This article delves into the importance of breast cancer screening, the statistics behind it, and the ongoing debate about over-diagnosis and over-treatment.
What to do if you have the hereditary breast and ovarian cancer gene BRCA
Once you have been diagnosed with having a problem with the hereditary breast and ovarian cancer gene BRCA, you need to take active steps to reduce your risk of developing early cancers.
